On this page
Which BPC-157 formats are featured on bpc-157.us?
Choose a format to compare: 10 mg powder vial, 15 mg prefilled pen, 60 capsules at 500 mcg each, or 30 mg nasal spray. The product cards bring together contents, original images and available documents.
Ordering is not yet available. For questions about the featured products or their records, email [email protected].
Choose a BPC-157 product format
Compare the contents, preparation and original documentation for each product.

BPC-157 10 mg
10 mg of freeze-dried BPC-157 powder. Original COA for lot PL-2609-010 included.
- Total BPC-157
- 10 mg
- Physical form
- Powder
- Preparation
- Reconstitution required
- Documented lot
- PL-2609-010

BPC-157 15 mg Pen
15 mg in a 3 mL prefilled pen. Concentration: 5 mg/mL.
- Total BPC-157
- 15 mg
- Liquid volume
- 3 mL
- Concentration
- 5 mg/mL
- Preparation
- Already in solution

BPC-157 500 mcg Capsules
500 mcg per capsule, 60 capsules per bottle, 30 mg total. Capsule-lot COA included.
- BPC-157 per capsule
- 500 mcg
- Capsules per bottle
- 60
- Total BPC-157
- 30 mg
- Documented lot
- PL-2609-012

BPC-157 30 mg Spray
150 mcg per spray, 30 mg per bottle. Premixed liquid; no reconstitution required.
- BPC-157 per bottle
- 30 mg
- BPC-157 per spray
- 150 mcg
- Physical form
- Liquid spray
- Preparation
- Premixed
The amounts above are label quantities. Match the batch report to the exact product format.
What should you compare before choosing a vial, pen, capsule or spray?
Start with the total quantity and the way the product is prepared or measured. A larger number on the package can refer to the whole container, a single capsule or a blend of ingredients.
| Format | Total contents | Preparation or unit | Question to resolve |
|---|---|---|---|
| Powder vial | 10 mg | Lyophilized powder; requires reconstitution | What final volume will determine the concentration?1 |
| Prefilled pen | 15 mg in 3 mL | Premixed at 5 mg/mL | What volume does the actual device deliver per setting?6 |
| Capsule bottle | 30 mg across 60 capsules | 500 mcg each; no reconstitution | Does the capsule batch match its content-assay report?2 |
| Nasal spray | 30 mg | Premixed; 150 mcg per spray | What are the actual fill volume and verified usable deliveries?3 |
The 3 mL pen volume does not disclose a click calibration. Likewise, the spray's total peptide quantity does not disclose liquid volume. Those device details need their own specifications.
Use the vial preparation guide, oral capsule guide and nasal spray guide for the format-specific questions. Available human evidence does not establish a conversion that makes oral, nasal and injected amounts equivalent.7
How far does one container go by arithmetic?
Use 1 mg = 1,000 mcg, then divide by the quantity being compared. The examples below describe inventory, not recommended doses or validated treatment courses.
| Container | Quantity example | Practical limit |
|---|---|---|
| 10 mg vial | 40 portions of 250 mcg, or 20 portions of 500 mcg | Arithmetic does not account for material left during handling. |
| 15 mg pen | 60 portions of 250 mcg, or 30 portions of 500 mcg | These are not verified device settings or usable-dose counts. |
| 60 capsules | 60 days at one daily; 30 days at two daily | Bottle duration does not establish an appropriate cycle. |
| 30 mg nasal spray | 30,000 ÷ 150 = 200 nominal spray amounts | Priming, residue and output consistency prevent promising 200 usable sprays. |
Keep supply duration separate from expiry after opening or preparation. Forty calculated portions do not establish forty usable days. For longer inventory examples, see the four-, six- and eight-week vial quantities.
How can you compare BPC-157 prices without confusing the formats?
Compare price per milligram within the same product format first. Divide the offered container price by its total BPC-157 content. Then compare documentation, usable contents and the final amount payable, including any shipping or tax.
| Product | Cost per mg | Useful second check |
|---|---|---|
| 10 mg vial | Vial price ÷ 10 | Which preparation supplies are included, if any? |
| 15 mg pen | Pen price ÷ 15 | Which device and instructions come with it? |
| 60 × 500 mcg capsules | Bottle price ÷ 30 | Cost per capsule = bottle price ÷ 60. |
| 30 mg spray | Bottle price ÷ 30 | Cost per usable spray requires a verified usable count. |
For a multipack, divide the full price by the full peptide quantity. Do not compare a bundle's total cost with a single vial's price. Equal cost per mg also does not establish equal absorption, effectiveness or quality across delivery routes.
What documentation is available for each product?
| Product | Available records | Coverage |
|---|---|---|
| Vial | Original vial COA; powder SDS | Results for the named vial lot, plus laboratory preparation and storage directions.1, 4 |
| Pen | Quantity and formulation specifications | Testing described for peptide input; no matching finished-pen COA was publicly linked in the reviewed records.6 |
| Capsules | Original capsule COA | Named-lot testing, including a separate composite content assay.2 |
| Spray | Bottle label; spray SDS | Contents and handling information; no matching finished-spray COA was publicly linked in the reviewed records.3, 5 |
The vial certificate reports 99.74% HPLC area purity for lot PL-2609-010. The capsule certificate reports 99.62% for lot PL-2609-012, plus an average of 494.7 mcg per capsule from a six-capsule composite. Both reports identify in-house testing.1, 2
The vial's purity does not measure its 10 mg fill; the pooled capsule assay does not show each capsule's content. The testing and COA guide explains those limits and the specific inconsistencies printed in the original reports.
What details should an order make clear?
- The exact item and quantity. Check compound, format, strength and number of containers, especially when comparing singles with bundles.
- The lot and supporting report. Check the sample type, laboratory and tests. Ask which document corresponds to the batch being supplied.
- Everything included. Confirm any diluent, needles, accessories and instructions. Items pictured beside a product are not automatically included.
- Handling during delivery. Ask how the applicable storage conditions are addressed in transit. Capsules, frozen powder storage and refrigerated liquids have different documented conditions.
- The complete purchase terms. Check the final price, delivery information, returns conditions and whether any recurring purchase is involved.
Retain the order details and the report matching the received lot. If the delivered label or batch differs, resolve that difference before relying on the earlier documentation.
Does a “BPC-157 near me” result confirm local availability?
No verified pickup location is listed here. A search result or nearby address does not confirm that a particular product is stocked, that a clinic supplies it or that the listed batch is available.
For an online listing or local enquiry, confirm the seller's identity, exact format, current availability and matching documentation directly. The FDA status and safety guide explains why a product listing should not be mistaken for approval as a medicine.
How do BPC-157-only products compare with BPC-157 + TB-500?
The four products above contain BPC-157 alone. The separate Wolverine vial contains 20 mg combined: 10 mg BPC-157 and 10 mg TB-500. The Wolverine pen contains 40 mg combined: 20 mg of each peptide in 3 mL.
Keep the combined amount and the BPC-157 amount separate when comparing packages or price. A 20 mg blend contains 10 mg of BPC-157, not 20 mg. The Wolverine stack guide covers both formats, component calculations and the reported combination schedules.
What commonly causes confusion when comparing products?
Does one capsule bottle contain as much BPC-157 as three vials?
Yes, by package quantity: 60 × 500 mcg equals 30 mg, as do three 10 mg vials. That equality does not establish equivalent absorption, effects or preparation requirements.
Does “COA available” mean independent testing?
Read the issuing laboratory details. The original vial and capsule reports here are explicitly in-house, with no outside laboratory report attached.
Is the largest container always the best value?
A larger pack may lower the nominal cost per mg, but the comparison also depends on storage, usable contents and documentation. Quantity alone cannot establish value or a suitable treatment course.
Can I inspect the documents before choosing a format?
Yes. Use the documents table for original files and Quality & Testing for their interpretation. Match the lot and formulation to the actual item being considered.
Where can you verify the package details?
- Original 10 mg vial COALot PL-2609-010; certificate PL-26-00010.
- Original 60 × 500 mcg capsule COALot PL-2609-012; certificate PL-26-00012.
- Original nasal-spray label30 mg total and 150 mcg per labeled spray.
- Vial safety data sheet PL-SDS-019Laboratory preparation and storage instructions.
- Spray safety data sheet PL-SDS-021Formulation and storage instructions.
- Featured pen specifications15 mg in 3 mL at 5 mg/mL; published product documentation rechecked November 2, 2026.
- FDA evaluation of BPC-157Available human evidence and pharmacokinetic limitations.
Product quantities are label claims unless a separate assay is identified. Original documents retain their stated testing scope.